Sofinnova Investments as of Sept. 30, 2021
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 70 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera Comm (NTRA) | 20.5 | $346M | 3.1M | 111.44 | |
Karuna Therapeutics Comm | 14.1 | $239M | 2.0M | 122.33 | |
Ascendis Pharma A/S Adr (ASND) | 4.7 | $80M | 500k | 159.39 | |
Aerovate Therapeutics Comm (AVTE) | 4.7 | $79M | 3.8M | 20.98 | |
AstraZeneca Adr (AZN) | 4.0 | $68M | 1.1M | 60.06 | |
Y-mAbs Therapeutics Comm (YMAB) | 3.7 | $63M | 2.2M | 28.54 | |
Vera Therapeutics Cl A (VERA) | 3.0 | $51M | 2.9M | 17.35 | |
Merck & Co Call Call Option | 2.7 | $45M | 600k | 75.11 | |
United Therapeutics Corp Comm (UTHR) | 2.4 | $41M | 222k | 184.58 | |
Bolt Biotherapeutics Comm (BOLT) | 2.1 | $35M | 2.8M | 12.65 | |
Align Technology Comm (ALGN) | 1.9 | $31M | 47k | 665.43 | |
Abbvie Comm (ABBV) | 1.7 | $29M | 273k | 107.87 | |
Galera Therapeutics Comm (GRTX) | 1.5 | $25M | 3.1M | 8.10 | |
Heron Therapeutics Comm (HRTX) | 1.5 | $25M | 2.3M | 10.69 | |
Bristol-Myers Squibb Call Call Option | 1.4 | $24M | 400k | 59.17 | |
Inozyme Pharma Comm (INZY) | 1.4 | $24M | 2.0M | 11.59 | |
Dexcom Comm (DXCM) | 1.2 | $20M | 37k | 546.85 | |
Blueprint Medicines Corp Comm (BPMC) | 1.1 | $19M | 182k | 102.81 | |
Regeneron Pharmaceuticals Put Put Option | 1.1 | $18M | 30k | 605.17 | |
Nextcure Comm (NXTC) | 1.1 | $18M | 2.7M | 6.74 | |
Akouos Comm | 1.0 | $18M | 1.5M | 11.61 | |
United Therapeutics Corp Put Put Option | 1.0 | $17M | 95k | 184.58 | |
Horizon Therapeutics Pub L SHS | 1.0 | $17M | 158k | 109.54 | |
Reata Pharmaceuticals Comm | 0.9 | $16M | 158k | 100.61 | |
Cytokinetics Comm (CYTK) | 0.9 | $15M | 427k | 35.74 | |
ObsEva SA Comm | 0.9 | $15M | 4.7M | 3.11 | |
Zoetis Cl A (ZTS) | 0.9 | $15M | 76k | 194.14 | |
Insmed Comm (INSM) | 0.9 | $15M | 535k | 27.54 | |
Sarepta Therapeutics Comm (SRPT) | 0.9 | $15M | 157k | 92.48 | |
Nucana Adr (NCNA) | 0.9 | $14M | 5.6M | 2.58 | |
Checkmate Pharmaceuticals Comm | 0.8 | $14M | 3.6M | 3.97 | |
Kura Oncology Comm (KURA) | 0.8 | $14M | 755k | 18.73 | |
Agenus Comm (AGEN) | 0.7 | $12M | 2.3M | 5.25 | |
Zymeworks Comm | 0.7 | $12M | 411k | 29.04 | |
Travere Therapeutics Comm (TVTX) | 0.6 | $11M | 437k | 24.25 | |
Exelixis Comm (EXEL) | 0.6 | $10M | 488k | 21.14 | |
Mirati Therapeutics Comm | 0.6 | $10M | 57k | 176.91 | |
Biogen Comm (BIIB) | 0.6 | $9.4M | 33k | 282.99 | |
Kadmon Holdings Comm | 0.5 | $9.1M | 1.0M | 8.71 | |
ChemoCentryx Comm | 0.5 | $8.9M | 518k | 17.10 | |
ChemoCentryx Put Put Option | 0.5 | $8.6M | 506k | 17.10 | |
PTC Therapeutics Comm (PTCT) | 0.5 | $8.6M | 230k | 37.21 | |
Intra-Cellular Therapies Comm (ITCI) | 0.5 | $8.5M | 227k | 37.28 | |
ALX Oncology Holdings Comm (ALXO) | 0.5 | $7.9M | 107k | 73.86 | |
Syndax Pharmaceuticals Comm (SNDX) | 0.5 | $7.9M | 414k | 19.11 | |
Celldex Therapeutics Comm (CLDX) | 0.4 | $7.4M | 137k | 53.99 | |
Acceleron Pharma Comm | 0.4 | $6.8M | 40k | 172.09 | |
Immatics Comm (IMTX) | 0.4 | $6.2M | 478k | 13.00 | |
Nucana Ordinary Shares | 0.4 | $6.2M | 2.4M | 2.58 | |
CTI BioPharma Corp Comm | 0.4 | $6.1M | 2.1M | 2.95 | |
Iveric Bio Comm | 0.3 | $5.8M | 357k | 16.24 | |
Amarin Corp Adr (AMRN) | 0.3 | $5.5M | 1.1M | 5.10 | |
Regenxbio Comm (RGNX) | 0.3 | $5.3M | 128k | 41.92 | |
Protagonist Therapeutics Call Call Option | 0.3 | $5.3M | 300k | 17.72 | |
Protagonist Therapeutics Comm (PTGX) | 0.3 | $5.3M | 298k | 17.72 | |
Guardant Health Comm (GH) | 0.3 | $5.0M | 40k | 125.00 | |
Jounce Therapeutics Comm | 0.3 | $4.7M | 637k | 7.43 | |
Sierra Oncology Comm | 0.3 | $4.5M | 207k | 21.92 | |
Cyteir Therapeutics Comm | 0.3 | $4.3M | 246k | 17.55 | |
Iveric Bio Put Put Option | 0.2 | $4.1M | 255k | 16.24 | |
Novocure Call Call Option | 0.2 | $3.5M | 30k | 116.17 | |
Intercept Pharmaceuticals In Call Call Option | 0.2 | $2.8M | 190k | 14.85 | |
Uniqure NV Comm (QURE) | 0.1 | $2.5M | 79k | 32.02 | |
PDS Biotechnology Corporation Comm (PDSB) | 0.1 | $2.1M | 143k | 14.90 | |
Aligos Therapeutics Comm (ALGS) | 0.1 | $1.9M | 124k | 15.51 | |
Marinus Pharmaceuticals Comm (MRNS) | 0.1 | $1.9M | 167k | 11.38 | |
Synlogic Comm | 0.1 | $1.8M | 575k | 3.05 | |
Fulcrum Therapeutics Comm (FULC) | 0.1 | $1.4M | 51k | 28.21 | |
Fusion Pharmaceuticals Comm (FUSN) | 0.0 | $618k | 78k | 7.92 | |
Insulet Corp Comm (PODD) | 0.0 | $303k | 1.1k | 284.24 |